Literature DB >> 23248073

Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery.

Ebru Nevin Cetin1, Cem Yıldırım.   

Abstract

Cataract surgical outcomes in diabetic patients has been subject to changes with the advances in the surgical techniques. Recent studies suggest that cataract surgery does not cause the progression of diabetic retinopathy and intravitreal bevacizumab and/or triamcinolone injections combined with cataract surgery may contribute in short term improvement of macular edema in diabetic patients. This article reviews the progression of diabetic retinopathy after cataract surgery with phacoemulsification and the use of adjuvant intravitreal treatments combined with phacoemusification in diabetic patients undergoing cataract surgery.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23248073     DOI： 10.1007/s10792-012-9695-1

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.031


  30 in total

1.  Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.

Authors:  Arsen Akinci; Orkun Muftuoglu; Alı Altınsoy; Ersel Ozkılıc
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

2.  Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema.

Authors:  Clécio Takata; Andre Messias; Marco S Folgosa; Levy R Lucena; Daniel R Lucena; Ingrid U Scott; Rodrigo Jorge
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

3.  Nonproliferative diabetic retinopathy and macular edema progression after phacoemulsification: prospective study.

Authors:  Pedro Romero-Aroca; Juan Fernández-Ballart; Matias Almena-Garcia; Isabel Méndez-Marín; Merce Salvat-Serra; Jose A Buil-Calvo
Journal:  J Cataract Refract Surg       Date:  2006-09       Impact factor: 3.351

4.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Authors:  Paul Mitchell; Francesco Bandello; Ursula Schmidt-Erfurth; Gabriele E Lang; Pascale Massin; Reinier O Schlingemann; Florian Sutter; Christian Simader; Gabriela Burian; Ortrud Gerstner; Andreas Weichselberger
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

5.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

Authors:  Michael J Elman; Neil M Bressler; Haijing Qin; Roy W Beck; Frederick L Ferris; Scott M Friedman; Adam R Glassman; Ingrid U Scott; Cynthia R Stockdale; Jennifer K Sun
Journal:  Ophthalmology       Date:  2011-04       Impact factor: 12.079

6.  Visual outcomes 12 months after phacoemulsification cataract surgery in patients with diabetes.

Authors:  Calvin Sze-Un Fong; Paul Mitchell; Elena Rochtchina; Tania de Loryn; Thomas Hong; Jie Jin Wang
Journal:  Acta Ophthalmol       Date:  2010-02-16       Impact factor: 3.761

7.  Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study.

Authors:  D S C Lam; C K M Chan; S Mohamed; T Y Y Lai; V Y W Lee; W W Lai; D S P Fan; W-M Chan
Journal:  Eye (Lond)       Date:  2005-08       Impact factor: 3.775

8.  Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.

Authors:  Arsen Akinci; Cosar Batman; Ersel Ozkilic; Ali Altinsoy
Journal:  Retina       Date:  2009 Nov-Dec       Impact factor: 4.256

9.  Role of combined cataract surgery and intravitreal bevacizumab injection in preventing progression of diabetic retinopathy: prospective randomized study.

Authors:  Rizwan A Cheema; Mahdi M Al-Mubarak; Yasir M Amin; Maheera A Cheema
Journal:  J Cataract Refract Surg       Date:  2009-01       Impact factor: 3.351

10.  Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.

Authors:  Katharina Krepler; Robert Biowski; Susanne Schrey; Kerstin Jandrasits; Andreas Wedrich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-08-21       Impact factor: 3.117
View more
  1 in total

1.  Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy.

Authors:  Alireza Khodabandeh; Shahed Fadaifard; Ali Abdollahi; Reza Karkhaneh; Ramak Roohipoor; Fatemeh Abdi; Hamed Ghasemi; Sam Habibollahi; Mehdi Mazloumi
Journal:  J Curr Ophthalmol       Date:  2018-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.